Press Releases Hangzhou Tigermed Consulting Co., Ltd

Equities

300347

CNE100001KV8

Biotechnology & Medical Research

End-of-day quote Shenzhen S.E. Other stock markets 2026-03-09			5-day change	1st Jan Change
56.53 ^CNY	-1.46%		-5.21%	-0.30%

Mar. 03	Frontage Unit Acquires Research Lab Firm from Tigermed Consulting Unit	MT
Feb. 13	Beijing Trimmune Biotech Co., Ltd. announced that it has received funding from Hangzhou Tigermed Consulting Co., Ltd	CI

Press Releases

23-08-28	Tigermed Reports 2023 Interim Results	AQ
21-04-30	Hangzhou Tigermed Consulting : 2020 Tigermed Sustainability Report And Environmental, Social and Governance Report	PU
21-04-20	Hangzhou Tigermed Consulting : Form of Proxy for the 2021 First H Share Class Meeting to be held on Friday, May 21, 2021	PU
21-04-20	Hangzhou Tigermed Consulting : NOTICE OF THE 2021 FIRST H SHARE CLASS MEETING	PU
21-04-20	Hangzhou Tigermed Consulting : Form of Proxy for the 2020 Annual General Meeting to be held on Friday, May 21, 2021	PU
21-03-29	Hangzhou Tigermed Consulting : (1) PROPOSED PARTIAL REPURCHASE AND CANCELLATION OF THE 2019 RESTRICTED A SHARES; (2) PROPOSED CHANGE OF THE REGISTERED CAPITAL OF THE COMPANY; AND (3) PROPOSED AMENDMENTS TO THE ARTICLES OF ASSOCIATION	PU
21-03-26	Hangzhou Tigermed Consulting : POLL VOTING RESULTS OF THE 2021 SECOND EXTRAORDINARY GENERAL MEETING HELD ON MARCH 26, 2021	PU
21-03-10	Hangzhou Tigermed Consulting : Notification Letter and Request Form to Non-Registered Holders	PU
21-03-10	Hangzhou Tigermed Consulting : Form of proxy for the 2021 Second Extraordinary General Meeting to be held on Friday, March 26, 2021	PU
21-03-10	Hangzhou Tigermed Consulting : NOTICE OF THE 2021 SECOND EXTRAORDINARY GENERAL MEETING	PU
21-03-10	Hangzhou Tigermed Consulting : PROPOSED ADOPTION OF THE SUBSIDIARY SHARE OPTION SCHEME; AND NOTICE OF THE 2021 SECOND EXTRAORDINARY GENERAL MEETING	PU
21-03-09	Hangzhou Tigermed Consulting : ANNOUNCEMENT - BOOK CLOSURE PERIOD FOR 2021 SECOND EXTRAORDINARY GENERAL MEETING	PU
20-08-30	Hangzhou Tigermed Consulting : FULL EXERCISE OF THE OVER-ALLOTMENT OPTION, STABILIZING ACTIONS AND END OF STABILIZATION PERIOD	PU
20-08-28	Hangzhou Tigermed Consulting : (1) PROPOSED PARTIAL REPURCHASE AND CANCELLATION OF THE 2019 RESTRICTED A SHARES; (2) PROPOSED CHANGE OF THE REGISTERED CAPITAL OF THE COMPANY; (3) PROPOSED CHANGE OF THE REGISTERED ADDRESS OF THE COMPANY; AND (4) PROPOSED AMENDMENTS TO THE ARTICLES OF ASSOCIATION	PU
20-08-10	Hangzhou Tigermed Consulting : 2019 Sustainability Report	PU
20-08-05	Hangzhou Tigermed Consulting : TERMS OF REFERENCE FOR THE STRATEGY DEVELOPMENT COMMITTEE OF THE BOARD OF DIRECTORS	PU
20-08-05	Hangzhou Tigermed Consulting : TERMS OF REFERENCE OF THE NOMINATION COMMITTEE OF THE BOARD OF DIRECTORS	PU
20-08-05	Hangzhou Tigermed Consulting : TERMS OF REFERENCE OF THE REMUNERATION AND EVALUATION COMMITTEE OF THE BOARD OF DIRECTORS	PU
20-08-05	Hangzhou Tigermed Consulting : TERMS OF REFERENCE OF THE AUDIT COMMITTEE OF THE BOARD OF DIRECTORS	PU
20-08-05	Hangzhou Tigermed Consulting : ARTICLES OF ASSOCIATION	PU
20-06-02	Hangzhou Tigermed Consulting : Tigermed Lauded by Frost & Sullivan for Its Rapid, Large-Scale Clinical Developmental Services	AQ
16-06-22	MacroStat : Receives 2016 Lilly Global Supplier Award	BU